A case of phaeochromocytoma in an eight-year-old child is presented with emphasis on drug preparation, fluid replacement, and intraoperative monitoring. Comparison with two previous cases is made to indicate advances in management.
INTRODUCTION
Phaeochromocytoma is a rare hormonally active tumour of the adrenal medulla. Its incidence in hypertensive populations specifically screened is approximately 0·5 per cent. The tumour secretes into the circulation excessive amounts of adrenaline, noradrenaline and dopamine in varying proportions, the clinical characteristics depending upon which catecholamine predominates.
The condition is very rare in childhood, documented cases coming to surgery at the Royal Alexandra Hospital for Children accounting for three in the past 20 years, viz. 1954, 1961 and 1973 . Some 7,000 operations are performed annually, giving an incidence of approximately 0 ·05 per cent.
CASE HISTORY
An eight-year-old girl was admitted in May, 1973, with symptoms of five months' duration. The relevant features were:
(i) Weight loss. During the symptomatic period she appeared thinner and her clothes became loose. (ii) Weakness and lethargy. She complained of excessive tiredness when swimming during the Christmas holidays and became much weaker in the month or so preceding admission, when she tired easily carrying her school case or climbing stairs.
(iii) Episodic vomiting of five months duration and induced by effort. (iv) Sweating, especially of the face and head, but not paroxysmal. There was no history of headaches, vasomotor phenomena or diarrhoea. On examination, the child was thin (20 kg) and hypertensive with blood pressure recordings of 230/190 mm Hg (supine) and 180/160 mm Hg (erect). The only other finding was a soft systolic ejection murmur at the left sternal edge.
A provisional diagnosis of "hypertension for investigation" was made and the child treated initially with reserpine 2·0 mg and methyldopa 250 mg twice daily.
Haematological and biochemical investigations revealed no abnormality other than an elevated urinary catecholamine level: free noradrenaline and adrenaline level of 2,500 [J-g/24 hr (normal values: 8-12 [J-g/24 hr). Aortography was subsequently performed under general anaesthesia without any specific preparation, but with ECG and blood pressure monitoring, during which the patient became markedly hypertensive. A diagnosis of a tumour of the right adrenal gland was made ( Figure 1 ). Following consultation with the Anaesthetic Department, it was decided to treat the child for a week prior to laparotomy with phenoxybenzamine in a dose of 1·0 mg/kg/day by mouth, resulting in control of blood pressure to acceptable levels. In the absence of gross tachycardia, it was considered that the administration of beta blockers was not indicated.
The anaesthetic management was as follows. The patient was premedicated (papaveretum 6·5 mg and hyoscine 0 ·15 mg) to avoid excessive emotional stimulation. Following institution of ECG monitoring, anaesthesia was induced with intravenous thiopentone (75 mg) and maintained with nitrous oxide and oxygen from a circle absorber system following endotracheal intubation facilitated by pancuronium 2·5 mg.
Pancuronium was chosen despite reports of hypertensive responses, as a compromise between d-tubocurarine with its risk of histamine release and hypotension, and gallamine causing tachycardia. Potent inhalational agents were avoided because of the theoretical hazard of arrhythmias in the presence of high levels of circulating endogenous catecholamines. An indwelling radial artery cannula (Argyle Intramedicut 20G) and a venous catheter (Intracath lSG) were inserted percutaneously to allow continuous monitoring of systemic arterial and central venous pressures respectively. Drugs prepared in appropriate dilution included phentolamine, propranolol, lignocaine and noradrenaline. Intravenous fluids (blood, Hartmann's solution, stable plasma protein solution) were administered as indicated by measured and estimated blood loss, pressure monitoring and serial haematocrit determinations to maintain central venous pressure levels at 5-8 mm Hg. The blood pressure remained stable at approximately 140/90 mm Hg until the tumour was exposed and handled, when it rose to 200/150 mm Hg. Phentolamine was then administered via a constant infusion pump at rates ranging from 100 [J-g/min to ~100 [J-g/min as determined by the response (Figure 2) . A right adrenalectomy was performed, and no further phentolamine was needed. The removal of a small tumour from the left adrenal gland was associated with a transient episode of hypotension (SO mm Hg systolic), which was corrected by fluid administration. This may have been caused by retractor compression of the inferior vena cava. Despite a tachycardia of 150/min, it was decided not to give propranolol unless the rate continued to rise. Neither of these events occurred. A total of 3,500 ml of fluid was infused without change in venous pressure, an index of the degree of preexisting vasoconstriction.
Monitoring of radial arterial pressure was continued for 24 hours, but no abnormal changes occurred. The post-operative course was uneventful and the patient was discharged 14 days after surgery, the urine noradrenaline plus adrenaline level having fallen to 27 [J-g per 24-hour specimen. 
DISCUSSION
Pre-operative preparation of the child with an alpha blocker (phenoxybenzamine) ensured a smooth induction and uneventful anaesthesia. Neither of the two previous patients admitted to the Royal Alexandra Hospital for Children in 1954 and 1961 received phenoxybenzamine prior to the operation. It is interesting to note that both had a stormy induction and required vasoconstrictors to support the circulation after removal of the tumour.
The first child, a boy of 14, but weighing less than 35 kg, presented with marked and constant hypertension, fundal changes, and an excess of noradrenaline in the urine. The response to phentolamine was typical. A right thoracic phaeochromocytoma was removed at operation. Records show that a considerable rise in blood pressure occurred at induction of anaesthesia, necessitating the administration of phentolamine. Severe post-operative hypotension ensued and a noradrenaline infusion was required to maintain blood pressure.
The second child, aged eight years and weighing 21 kg, had a high sustained blood pressure, the diastolic often over 130 mm Hg, with paroxysmal sweating, loss of weight, and polyuria. The phentolamine test was reported as " strikingly positive" and urinary catecholamines were increased (800 [J.g of noradrenaline in 24 hours). Pre-operatively an attempt was made to control his blood pressure "within reasonable limits" by large doses of phentolamine. However, at operation, when traction was applied to the tumour the blood pressure rose to 300 mm Hg systolic, necessitating large doses of phentolamine for control. After removal of the tumour, the blood pressure dropped to below 80 mm Hg systolic and it was necessary to maintain it with a noradrenaline infusion for more than] 2 hours.
All patients in the series made a good recovery, but the management of the most recent case with a pre-operative course of phenoxybenzamine has demonstrated the advantage of alpha adrenergic blockade in con trolling sustained hypertension in the preparation of patients with phaeochromocytoma for surgery.
The concomitant routine administration of beta blockers, as suggested by Rosset et al. (1967) prior to surgery and intra-operatively, is less justifiable. We have proposed that the indications for their use are either a marked sustained tachycardia, or an increasing heart rate with evidence of failure of cardiac output as a consequence. Obviously that degree of tachycardia at which a beta blocker is given is empirical, and it seems to us that each case must be judged on its merits. A summary of the proposed management of these cases appears in Table 1. 
